[1. Shen X, Lee K, König R. Effects of heavy metal ions on resting and antigenactivated CD4(+) T cells. Toxicology 2001;169:67-80. doi: 10.1016/S0300-483X(01)00483-810.1016/S0300-483X(01)00483-8]Open DOISearch in Google Scholar
[2. Metryka E, Chibowska K, Gutowska I, Falkowska A, Kupnicka P, Barczak K, Chlubek D, Baranowska-Bosiacka I. Lead (Pb) Exposure enhances expression of factors associated with inflammation Int J Mol Sci 2018;19:1813. doi: 10.3390/ijms1906181310.3390/ijms1906181329925772603240929925772]Open DOISearch in Google Scholar
[3. Mrowicki J, Mrowicka M, Dziki A, Dziki L, Majsterek I. Etiopathogenesis of inflammatory bowel diseases. Biomark J 2018;4:8. doi: 10.21767/2472-1646.10004610.21767/2472-1646.100046]Open DOISearch in Google Scholar
[4. Libby P, Ridker PM, Hansson GK; Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-38. doi: 10.1016/j.jacc.2009.09.00910.1016/j.jacc.2009.09.009283416919942084]Open DOISearch in Google Scholar
[5. Falk E. Pathogenesis of atherosclerosis. J Am Coll Cardiol 2006;47(Suppl):C7-C12. doi: 10.1016/j.jacc.2005.09.06810.1016/j.jacc.2005.09.06816631513]Open DOISearch in Google Scholar
[6. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006;86:515-81. doi: 10.1152/physrev.00024.200510.1152/physrev.00024.200516601268]Open DOISearch in Google Scholar
[7. Ross R, Glomset JA. The pathogenesis of atherosclerosis. N Engl J Med 1976;295:369-77. doi: 10.1056/NEJM19760812295070710.1056/NEJM197608122950707819830]Open DOISearch in Google Scholar
[8. Boulay JL, O’Shea JJ, Paul WE. Molecular phylogeny within type I cytokines and their cognate receptors. Immunity 2003;19:159-63. doi: 10.1016/S1074-7613(03)00211-51293234910.1016/S1074-7613(03)00211-5]Search in Google Scholar
[9. Navas-Acien A, Guallar E, Silbergeld E, Rothenberg SJ. Lead exposure and cardiovascular disease: a systematic review. Environ Health Perspect 2006;115:472-82. doi: 10.1289/ehp.978510.1289/ehp.9785184994817431501]Open DOISearch in Google Scholar
[10. Aoki Y, Brody DJ, Flegal KM, Fakhouri TH, Parker JD, Axelrad DA. Blood lead and other metal biomarkers as risk factors for cardiovascular disease mortality. Medicine (Baltimore) 2016;95:e2223. doi: 10.1097/MD.000000000000222310.1097/MD.0000000000002223470624926735529]Search in Google Scholar
[11. Lustberg M, Silbergeld E. Blood lead levels and mortality. Arch Intern Med 2002;162:2443-9. doi: 10.1001/archinte.162.21.244310.1001/archinte.162.21.244312437403]Open DOISearch in Google Scholar
[12. Menke A, Muntner P, Batuman V, Silbergeld EK, Guallar E. Blood lead below 0.48 μmol/L (10 μg/dL) and mortality among US adults. Circulation 2006;114:1388-94. doi: 10.1161/CIRCULATIONAHA.106.62832110.1161/CIRCULATIONAHA.106.628321]Search in Google Scholar
[13. Lanphear BP, Rausch S, Auinger P, Allen RW, Hornung RW. Low-level lead exposure and mortality in US adults: a population-based cohort study. Lancet Public Health 2018;3:e177-84. doi: 10.1016/S2468-2667(18)30025-210.1016/S2468-2667(18)30025-2]Open DOISearch in Google Scholar
[14. Krocova Z, Macela A, Kroca M, Hernychova L. The immunomodulatory effect(s) of lead and cadmium on the cells of immune system in vitro. Toxicol In Vitro 2000;14:33-40. doi: 10.1016/S0887-2333(99)00089-210.1016/S0887-2333(99)00089-2]Open DOISearch in Google Scholar
[15. Flohé SB, Brüggemann J, Herder C, Goebel C, Kolb H. Enhanced proinflammatory response to endotoxin after priming of macrophages with lead ions. J Leukoc Biol 2002;71:417-24. doi: 10.1189/jlb.71.3.41710.1189/jlb.71.3.417]Open DOISearch in Google Scholar
[16. Huo Y, Hafezi-Moghadam A, Ley K. Role of vascular adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesion. Circ Res 2000;87:153-9. doi: 10.1161/01.RES.87.2.15310.1161/01.RES.87.2.153]Open DOISearch in Google Scholar
[17. Cybulsky MI, Iiyama K, Li H, Zhu S, Chen M, Iiyama M, Davis V, Gutierrez-Ramos JC, Connely PW, Milstone DS. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest 2001;107:1255-62. doi: 10.1172/JCI1187110.1172/JCI11871]Open DOISearch in Google Scholar
[18. Rapisarda V, Ledda C, Ferrante M, Fiore M, Cocuzza S, Bracci M, Fenga C. Blood pressure and occupational exposure to noise and lead (Pb): A cross-sectional study. Toxicol Ind Health 2016;32:1729-36. doi : 10.1177/074823371557661610.1177/0748233715576616]Open DOISearch in Google Scholar
[19. Yücesoy B, Turhan A, Üre M, Imir T, Karakaya A. Effects of occupational lead and cadmium exposure on some immunoregulatory cytokine levels in man. Toxicology 1997;21;123:143-7. doi: 10.1016/S0300-483X(97)00107-810.1016/S0300-483X(97)00107-8]Open DOISearch in Google Scholar
[20. Machoń-Grecka A, Dobrakowski M, Kasperczyk A, Birkner E, Pryzwan T, Kasperczyk S. The effect of subacute lead exposure on selected blood inflammatory biomarkers and angiogenetic factors. J Occup Health 2018;60:369-75. doi: 10.1539/joh.2017-0307-OA10.1539/joh.2017-0307-OA617602830122729]Open DOISearch in Google Scholar
[21. Chmurzyńska A. The multigene family of fatty acid-binding proteins: function, structure and polymorphism. J Appl Genet 2006;47:39-48. doi: 10.1007/BF0319459710.1007/BF0319459716424607]Open DOISearch in Google Scholar
[22. Başar O, Akbal E, Köklü S, Tuna Y, Koçak E, Başar N, Tok D, Erbiş H, Senes M. Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis. Herz 2013;38:417-22. doi: 10.1007/s00059-012-3714-x10.1007/s00059-012-3714-x23324907]Open DOISearch in Google Scholar
[23. Beysel S, Kizilgul M, Ozbek M, Çalışkan M, Kan S, Apaydın M, Ozcelik O, Cakal E. Heart-type fatty acid binding protein levels in elderly diabetics without known cardiovascular disease. Clin Interv Aging 2017;12:2063-8. doi: 10.2147/CIA.S13724710.2147/CIA.S137247572200629255351]Search in Google Scholar
[24. Centers for Disease Control and Prevention (CDC). Blood Lead Levels---United States, 1999--2002. MMWR. May 27, 2005; 54(20):513-516.]Search in Google Scholar
[25. ACGIH® Threshold Limit Values (TLVs®) and Biological Exposure Indices (BEIs®). Appendix B, 2012. [displayed 28 January 2019]. Available at https://www.nsc.org/Portals/0/Documents/facultyportal/Documents/fih-6e-appendix-b.pdf]Search in Google Scholar
[26. Aliyev V, Kayaalti Z, Kaplan B, SoylemezogluT. Effect of GST polymorphisms on as levels of placental and maternal biological samples. Toxicol Lett 2012;211:S43-S216. doi: 10.1016/j.toxlet.2012.03.26110.1016/j.toxlet.2012.03.261]Open DOISearch in Google Scholar
[27. Valentino M, Rapisarda V, Santarelli L, Bracci M, Scorcelletti M, Di Lorenzo L, Cassano F, Soleo L. Effect of lead on the levels of some immunoregulatory cytokines in occupationally exposed workers. Hum Exp Toxicol 2007;26:551-6. doi: 10.1177/096032710707381710.1177/096032710707381717884957]Open DOISearch in Google Scholar
[28. Kasperczyk A, Dobrakowski M, Czuba ZP, Horak S, Kasperczyk S. Environmental exposure to lead induces oxidative stress and modulates the function of the antioxidant defense system and the immune system in the semen of males with normal semen profile. Toxicol Appl Pharmacol 2015;284:339-44. doi: 1016/j.taap.2015.03.00110.1016/j.taap.2015.03.00125771126]Search in Google Scholar
[29. Karbek B, Ozbek M, Bozkurt NC, Ginis Z, Gungunes A, Unsal IO, Cakal E, Delibası T. Heart-Type Fatty Acid Binding Protein (H-FABP): Relationship with arterial ıntima-media thickness and role as diagnostic marker for atherosclerosis in patients with impaired glucose metabolism. Cardiovasc Diabetol 2011;10:37. doi: 10.1186/1475-2840-10-3710.1186/1475-2840-10-37311239121535886]Open DOISearch in Google Scholar
[30. Tanaka T, Sohmiya KI, Kitaura Y, Takeshita H, Morita H, Ohkaru Y, Asayama K, Kimura H. Clinical evaluation of point-of-care-testing of heart-type fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardial infarction. J Immunoassay Immunochem 2006;27:225-38. doi: 10.1080/1532181060073491910.1080/1532181060073491916827225]Open DOISearch in Google Scholar
[31. Jeong JH, Seo JH, Ahn JY, Kim KH, Seo JY, Kim MJ, Lee HT, Park PW. The prognostic value of serum levels of heart-type fatty acid binding protein and high sensitivity C reactive protein in patients with increased levels of amino-terminal pro-B type natriuretic peptide. Ann Lab Med 2016;36:420-6. doi: 10.3343/alm.2016.36.5.42010.3343/alm.2016.36.5.420494048427374706]Open DOISearch in Google Scholar
[32. Davies MJ, Gordon JL, Gearing AJH, Pigott R, Woolf N, Katz D, Kyriakopoulos A. The expression of the adhesion molecules ICAM- 1, VCAM- 1, PECAM, and E-selectin in human atherosclerosis. J Pathol 1993;171:223-9. doi: 10.1002/path.171171031110.1002/path.17117103117506307]Open DOISearch in Google Scholar
[33. Nahrendorf M, Keliher E, Panizzi P, Zhang H, Hembrador S, Figueiredo JL, Aikawa E, Kelly K, Libby P, Weissleder R. 18F-4V for PET–CT imaging of VCAM-1 expression in atherosclerosis. JACC Cardiovasc Imaging 2009;2:1213-22. doi: 10.1016/j.jcmg.2009.04.01610.1016/j.jcmg.2009.04.016277312919833312]Open DOISearch in Google Scholar
[34. Johnston-Cox HA, Koupenova M, Ravid K. A2 adenosine receptors and vascular pathologies. Arterioscler Thromb Vasc Biol 2012;32:870-8. doi: 10.1161/ATVBAHA.112.24618110.1161/ATVBAHA.112.246181575535922423039]Search in Google Scholar
[35. Futterman LG, Lemberg L. Novel markers in the acute coronary syndrome: BNP, IL-6, PAPP-A. Am J Crit Care 2002;11:168-72. PMID: 1969064210.4037/ajcc2002.11.2.168]Search in Google Scholar
[36. Cung H, Aragon MJ, Zychowski K, Anderson JR, Nawarskas J, Roldan C, Sood A, Qualls C, Campen MJ. Characterization of a novel endothelial biosensor assay reveals increased cumulative serum inflammatory potential in stabilized coronary artery disease patients. J Transl Med 2015;13:99. doi: 10.1186/s12967-015-0457-510.1186/s12967-015-0457-5437634725890092]Open DOISearch in Google Scholar